Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 189.06 ($2.54) and traded as high as GBX 190 ($2.55). Spire Healthcare Group shares last traded at GBX 188.64 ($2.53), with a volume of 311,395 shares trading hands.
Analyst Ratings Changes
Separately, Deutsche Bank Aktiengesellschaft dropped their target price on shares of Spire Healthcare Group from GBX 320 ($4.30) to GBX 300 ($4.03) and set a "buy" rating on the stock in a research report on Thursday, March 6th.
Read Our Latest Report on SPI
Spire Healthcare Group Stock Performance
The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The company's fifty day moving average price is GBX 189.06 and its 200 day moving average price is GBX 212.77. The company has a market cap of £757.54 million, a PE ratio of 26.85, a P/E/G ratio of 1.06 and a beta of 0.96.
Spire Healthcare Group (LON:SPI - Get Free Report) last posted its earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.12) earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. On average, equities research analysts predict that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.
Spire Healthcare Group Increases Dividend
The business also recently announced a dividend, which will be paid on Friday, June 20th. Shareholders of record on Thursday, May 22nd will be issued a GBX 2.30 ($0.03) dividend. This represents a yield of 1.29%. This is an increase from Spire Healthcare Group's previous dividend of $2.10. The ex-dividend date is Thursday, May 22nd. Spire Healthcare Group's payout ratio is 42.70%.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
